EP 3074418 A2 20161005 - VACCINE COMPOSITION FOR PREVENTING AND/OR TREATING LEISHMANIASES; IMMUNOGENIC PEPTIDES; AND METHOD FOR OBTAINING SAME
Title (en)
VACCINE COMPOSITION FOR PREVENTING AND/OR TREATING LEISHMANIASES; IMMUNOGENIC PEPTIDES; AND METHOD FOR OBTAINING SAME
Title (de)
IMPFSTOFFZUSAMMENSETZUNG ZUR VORBEUGUNG UND/ODER BEHANDLUNG VON LEISHMANIOSE, IMMUNOGENE PEPTIDE UND VERFAHREN ZUR HERSTELLUNG DAVON
Title (fr)
COMPOSITION VACCINALE POUR LA PREVENTION ET/OU LE TRAITEMENT DE LEISHMANIOSES, PEPTIDES IMMUNOGENES ET PROCEDE D'OBTENTION
Publication
Application
Priority
- FR 1361823 A 20131129
- IB 2014066425 W 20141128
Abstract (en)
[origin: WO2015079420A2] The invention relates to the use, as a vaccine molecule in a mammal, of a PSA, such as a Leishmania PSA, or a part of said PSA having immunogenic properties. Said PSA, hereinafter referred to as "ES PSAr", is in a soluble, native, recombinant form. The invention also relates to a vaccine composition for preventing and/or treating Leishmaniases containing an ES PSAr protein.
IPC 8 full level
C07K 14/44 (2006.01); A61K 39/008 (2006.01)
CPC (source: EP)
A61K 39/008 (2013.01); A61P 33/02 (2017.12); C07K 14/44 (2013.01); Y02A 50/30 (2017.12)
Citation (search report)
See references of WO 2015079420A2
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2015079420 A2 20150604; WO 2015079420 A3 20151112; BR 112016012097 A2 20201110; EP 3074418 A2 20161005; FR 3014103 A1 20150605; FR 3014103 B1 20190816
DOCDB simple family (application)
IB 2014066425 W 20141128; BR 112016012097 A 20141128; EP 14830587 A 20141128; FR 1361823 A 20131129